Characterization of the cytotoxic factor(s) released from thymic dendritic cells upon human immunodeficiency virus type 1 infection

Virology

Volumn 241, Issue 2, 1998, Pages 285-297

  Beaulieu, Sylvie ^a   Lafontaine, Marielle ^a   Richer, Martin ^a   Courchesne, Isabelle ^a   Cohen, Eric A ^a   Bergeron, Dominique ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYCLOHEXIMIDE; CYTOTOXIC FACTOR;

ARTICLE; CELL DEATH; CELL KILLING; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; PRIORITY JOURNAL; THYMOCYTE; VIRUS ISOLATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032519894     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8977     Document Type: Article

References (61)

1. Aldrovandi G. M., Feuer G., Gao L., Jamieson B., Kristeva M., Chen I. S. Y., Zack J. A. The SCID-hu mouse as a model for HIV-1 infection. Nature. 363:1993;732-736.
2. Ameisen J. C. Programmed cell death (apoptosis) and cell survival regulation: relevance to AIDS and cancer. AIDS. 8:1994;1197-1213.
3. Badley A. D., McElhinny J. A., Leibson P. J., Lynch D. H., Alderson M. R., Paya C. V. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol. 70:1996;199-206.
4. Badley A. D., Dockrell D., Simpson M., Schutt R., Lynch D. H., Leibson P., Paya C. V. Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J. Exp. Med. 185:1997;55-64.
5. Banda N. K., Bernier J., Kurahara D. K., Kurrle R., Haigwood N., Sékaly R.-P., Finkel T. H. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J. Exp. Med. 176:1992;1099-1106.
6. Beaulieu S., Landry D., Bergeron D., Cohen E. A., Montplaisir S. An improved method for purifying human thymic dendritic cells. J. Immunol. Methods. 180:1995;225-236.
7. Beaulieu S., Kessous A., Landry D., Montplaisir S., Bergeron D., Cohen E. A. In vitro characterization of purified human thymic dendritic cells infected with human immunodeficiency virus type 1. Virology. 222:1996;214-226.
8. Bérubé P., Barbeau B., Cantin R., Sékaly R.-P., Tremblay M. Repression of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by binding of the virus to its primary cellular receptor, the CD4 molecules. J. Virol. 70:1996;4009-4016.
9. Bonyhadi M. L., Rabin L., Salimi S., Brown D. A., Kosek J., McCune J. M., Kaneshima H. HIV induces thymus depletion in vivo. Nature. 363:1993;728-732.
10. +. AIDS Res. Hum. Retroviruses. 10:1994;61-71.
11. Cameron P. U., Lowe M. G., Sotzik F., Coughlan A. F., Crowe S. M., Shortman K. The interaction of macrophage and non-macrophage tropic isolates of HIV-1 with thymic and tonsillar dendritic cells in vitro. J. Exp. Med. 183:1996;1851-1856.
12. Chirmule N., Pahwa S. Envelope glycoproteins of human immunodeficiency virus type 1: Profound influences on immune functions. Microbiol. Rev. 60:1996;386-406.
13. Clouse K. A., Cosentino L. M., Weih K. A., Pyle S. W., Robbins P. B., Hochstein H. D., Natarajan V., Farrar W. L. The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J. Immunol. 147:1991;2892-2901.
14. Coffin J. M. HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy. Science. 267:1995;483-489.
15. +. Cell. Immunol. 151:1993;392-403.
16. De Rossi A., Calabro M. L., Panozzo M., Bernardi D., Caruso B., Tridente G., Chieco-Bianchi L. In vitro studies of HIV-1 infection in thymic lymphocytes: A putative role of the thymus in AIDS pathogenesis. AIDS Res. Hum. Retroviruses. 6:1990;287-198.
17. Fadeel B., Thorpe C. J., Yonehara S., Chiodi F. Anti-Fas IgG1 antibodies recognizing the same epitope of Fas/APO-1 mediate different biological effects in vitro. Int. Immunol. 9:1997;201-209.
18. Fauci A. S. Host factors and the pathogenesis of HIV-induced disease. Nature. 384:1996;529-534.
19. +. J. Immunol. 152:1994;4649-4662.
20. Finkel T. H., Banda N. K. Indirect mechanism of HIV pathogenesis: how does HIV kill T cells? Curr. Opin. Immunol. 6:1994;605-615.
21. Finkel T. H., Tudor-Williams G., Banda N. K., Cotton F. M., Curiel T., Monks C., Baba T. W., Ruprecht R. M., Kupfer A. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med. 1:1995;129-134.
22. Garry R. F. Potential mechanisms for the cytopathic properties of HIV. AIDS. 3:1989;683-694.
23. Ghanekar S. A., Logar A. J., Rinaldo C. R. Expression of cytokine mRNA by human peripheral blood dendritic cells stimulated with human immunodeficiency virus and herpes simplex virus. Adv. Exp. Med. Biol. 378:1995;435-437.
24. Gibellini D., Zauli G., Re M. C., Milani D., Furlini G., Caramelli E., Capitani S., LaPlaca M. Recombinant human immunodeficiency virus type-1 (HIV-1) Tat protein sequentially up-regulates IL-6 and TGF-β1 mRNA expression and protein synthesis in peripheral blood monocytes. Br. J. Haematol. 88:1994;261-267.
25. Gibellini D., Caputo A., Celeghini C., Bassini A., LaPlaca M., Capitani S., Zauli G. Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including human immunodeficiency virus-type 1 (HIV-1) infection. Br. J. Haematol. 89:1995;24-33.
26. Gougeon M.-L., Olivier R., Garcia S., Guetard D., Dragic T., Dauquet C., Montagnier L. Mise en évidence d'un processus d'engagement vers la mort cellulaire par apoptose dans les lymphocytes de patients infectés par le VIH. C. R. Acad. Sci. 312:1991;529-537.
27. +. J. Exp. Med. 175:1992;331-340.
28. Ho D. D., Neumann A. U., Perelson A. S., Chen W., Leonard J. M., Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 373:1995;123-126.
29. Joshi V. V., Oleske J. M., Saad S., Gadol C., Connor E., Bobila R., Minnefor A. B. Thymus biopsy in children with acquired immunodeficiency syndrome. Arch. Pathol. Lab. Med. 110:1986;837-842.
30. Laurent-Crawford A. G., Krust B., Rivière Y., Desgranges C., Muller S., Kieny M. P., Dauguet C., Hovanessian A. G. Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res. Human Retro. 9:1993;761-773.
31. Levy J. A. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57:1993;183-289.
32. +. J. Virol. 68:1994;390-399.
33. Lynch D. H., Ramsdell F., Alderson M. R. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today. 16:1995;569-574.
34. Mano H., Chermann J.-C. Fetal human immunodeficiency virus type 1 infection of different organs in the second trimester. AIDS Res. Hum. Retroviruses. 7:1991;83-88.
35. McDougal S. D., Nicholson G., Gross D., Cort S. P., Kennedy S., Mawle A. C. Binding of the human retrovirus HTLV III/LAV to the CD4 (T4) molecule: Conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimiary. J. Immunol. 137:1986;2937-2944.
36. Meyaard L., Otto S. A., Jonker R. R., Mijnster M. T., Keet R. P. M., Miedema F. Programmed death of T cells in HIV-1 infection. Science. 257:1992;217-219.
37. +. J. Clin. Immunol. 15:1995;130S-133S.
38. Muro-Cacho C. A., Pantaleo G., Fauci A. S. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissus and not with stage of disease or viral burden. J. Immunol. 154:1995;5555-5566.
39. Nagata S., Golstein P. The Fas death factor. Science. 267:1995;1449-1456.
40. +. Proc. Natl. Acad. Sci. USA. 92:1995;7312-7316.
41. Oyaizu N., McCloskey T. W., Than S., Hu R., Kalyanaraman V. S., Pahwa S. Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-γ and tumor necrosis factor-α secretion. Blood. 84:1994;2622-2631.
42. Oyaizu N., Pahwa S. Role of apoptosis in HIV disease pathogenesis. J. Clin. Immunol. 15:1995;217-231.
43. Pantaleo G., Fauci A. S. New concepts in the immunopathogenesis of HIV. Annu. Rev. Immunol. 13:1995;487-512.
44. Papiernik M., Brossard Y., Mulliez N., Roune J., Brechot C., Barin F., Goudeau A., Bach J.-F., Griscelli C., Henrion R., Vazeux R. Thymic abnormalities in fetuses aborted from human immunodeficiency virus type 1 seropositive women. Pediatrics. 89:1992;297-301.
45. Purvis S. F., Jacobberger J. W., Sramkoski R. M., Patki A. H., Lederman M. M. HIV type 1 Tat protein induces apoptosis and death in Jurkat cells. AIDS Res. Hum. Retroviruses. 11:1995;443-450.
46. Rosenberg Z. F., Fauci A. S. Immunopathogenic mechanisms of HIV infection: Cytokine induction of HIV expression. Immunol. Today. 11:1990;176-180.
47. Sandborg C. I., Imfeld K. L., Zaldivar F. Jr., Berman M. A. HIV type 1 induction of interleukin 1 and 6 production by human thymic cells. AIDS Res. Hum. Retroviruses. 10:1994;1221-1229.
48. Schmidtmayerova H., Nottet H. S., Nuovo G., Raabe T., Flanagan C. R., Dubrovsky L., Gendelman H. E., Cerami A., Bukrinsky M., Sherry B. Human immunodeficiency virus type 1 infection alters chemokine β peptide expression in human monocytes: Implications for recruitment of leukocytes into brain and lymph nodes. Proc. Natl. Acad. Sci. USA. 93:1996;700-704.
49. +++. Proc. Natl. Acad. Sci. USA. 87:1990;7727-7731.
50. Sekigawa I., Koshino K., Hishikawa T., Kaneko H., Takasaki Y., Hashimoto H., Hirose S.-I., Inagaki Y., Yamamoto N. Inhibitory effect of the immunosuppressant FK506 on apoptotic cell death induced by HIV-1 gp120. J. Clin. Immunol. 15:1995;312-317.
51. Smith C., Farrah T., Goodwin R. G. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell. 76:1994;959-962.
52. Stanley S. K., McCune J. M., Kaneshima H., Justement J. S., Sullivan M., Boone E., Baseler M., Adelsberger J., Bonyhadi M., Orenstein J., Fox C. H., Fauci A. S. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J. Exp. Med. 178:1993;1151-1163.
53. Su L., Kaneshima H., Bonyhadi M., Salimi S., Kraft D., Rabin L., McCune J. M. HIV-1-induced thymocyte depletion is associated with indirect cytopathicity and infection of progenitor cells in vivo. Immunity. 2:1995;25-36.
54. Tanaka M., Suda T., Takahashi T., Nagata S. Expression of the functional soluble form of human fas ligand in activated lymphocytes. Embo J. 14:1995;1129-1135.
55. Tremblay M., Numazaki K., Goldman H., Wainberg M. A. Infection of human thymic lymphocytes by HIV-1. J. AIDS. 3:1990;356-360.
56. +. Eur. J. Immunol. 25:1995;2907-2916.
57. Valentin H., Nugeyre M. T., Vuillier F., Boumsell L., Schmid M., Barré-Sinoussi F., Pereira R. A. Two subpopulations of human triple-negative thymic cells are susceptible to infection by human immunodeficiency virus type 1 in vitro. J. Virol. 68:1994;3041-3050.
58. Wei X., Ghosh S. K., Taylor M. E., Johnson V. A., Emini E. A., Deutsch P., Lifson J. D., Bonhoeffer S., Nowak M. A., Hahn B. H., Saag M. S., Shaw G. M. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 373:1995;117-122.
59. Weisman D., Fauci A. Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection. Clin. Microbiol. Rev. 10:1997;358-367.
60. Westendorp M. O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K.-M., Krammer P. H. Sensitization of T cell to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature. 375:1995;497-500.
61. +. J. Exp. Med. 183:1996;99-108.